SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Charles E. Begley, Tracy L. Durgin, The direct cost of epilepsy in the United States: A systematic review of estimates, Epilepsia, 2015, 56, 7
  2. 2
    Marta Maschio, Francesco Paladin, Epilepsy and Brain Tumors, 2015,

    CrossRef

  3. 3
    Rami Ben-Joseph, Chi-Chang Chen, Ajita P. De, Rolin L. Wade, Dhvani Shah, Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans, Journal of Medical Economics, 2014, 17, 10, 708

    CrossRef

  4. 4
    Yeeck Sim, Brandon Nokes, Seenu Byreddy, Jenny Chong, Bruce M. Coull, David M. Labiner, Healthcare utilization of patients with epilepsy in Yuma County, Arizona: Do disparities exist?, Epilepsy & Behavior, 2014, 31, 307

    CrossRef

  5. You have free access to this content5
    Vicki R. Kee, Brad Gilchrist, Mark A. Granner, Nicola R. Sarrazin, Ryan M. Carnahan, A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  6. 6
    Andrew N. Wilner, Bal K. Sharma, Alison Soucy, Andrew Krueger, Health plan paid cost of epilepsy in 2009 in the U.S., Epilepsy & Behavior, 2012, 25, 3, 412

    CrossRef

  7. 7
    Chuen-Chau Chang, Chaur-Jong Hu, Fai Lam, Hang Chang, Chien-Chang Liao, Ta-Liang Chen, Postoperative adverse outcomes in surgical patients with epilepsy: A population-based study, Epilepsia, 2012, 53, 6
  8. 8
    Jenny Chong, Hemant S. Kudrimoti, Darlene C.W. Lopez, David M. Labiner, Behavioral risk factors among Arizonans with epilepsy: Behavioral Risk Factor Surveillance System 2005/2006, Epilepsy & Behavior, 2010, 17, 4, 511

    CrossRef

  9. 9
    Sandra L. Helmers, Pierre Emmanuel Paradis, Ranjani Manjunath, Mei Sheng Duh, Marie-Hélène Lafeuille, Dominick Latrémouille-Viau, Patrick Lefebvre, David M. Labiner, Economic burden associated with the use of generic antiepileptic drugs in the United States, Epilepsy & Behavior, 2010, 18, 4, 437

    CrossRef

  10. 10
    J. Jaime Caro, Krista F. Huybrechts, Case-Control Studies in Pharmacoeconomic Research, PharmacoEconomics, 2009, 27, 8, 627

    CrossRef

  11. 11
    Woodie M. Zachry, Quynhchau D. Doan, Brien J. Smith, Jerry D. Clewell, Jenny M. Griffith, Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting, Epilepsy & Behavior, 2009, 16, 2, 268

    CrossRef

  12. 12
    Jacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis, Dominick Latrémouille-Viau, Patrick Lefebvre, Ranjani Manjunath, Odile Sheehy, Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting, Current Medical Research and Opinion, 2008, 24, 4, 1069

    CrossRef

  13. 13
    Nathalie Jetté, Hude Quan, Peter Faris, Stafford Dean, Bing Li, Andrew Fong, Samuel Wiebe, Health resource use in epilepsy: Significant disparities by age, gender, and aboriginal status, Epilepsia, 2008, 49, 4
  14. 14
    William O. Tatum, Sam Al-Saadi, Thomas L. Orth, Outpatient case management in low-income epilepsy patients, Epilepsy Research, 2008, 82, 2-3, 156

    CrossRef

  15. 15
    Won Chan Lee, Marc S. Hoffmann, Steve Arcona, Joseph D'Souza, Qin Wang, Chris L. Pashos, A cost comparison of alternative regimens fortreatment-refractory partial seizure disorder: An econometric analysis, Clinical Therapeutics, 2005, 27, 10, 1629

    CrossRef

  16. 16
    Demetris Pillas, MSc, Caroline Selai, Economic aspects of epilepsy and antiepileptic treatment: a review of the literature, Expert Review of Pharmacoeconomics & Outcomes Research, 2005, 5, 3, 327

    CrossRef

  17. 17
    Ettore Beghi, Livio Garattini, Elena Ricci, Dante Cornago, Fabio Parazzini, Direct Cost of Medical Management of Epilepsy among Adults in Italy: A Prospective Cost-of-Illness Study (EPICOS), Epilepsia, 2004, 45, 2
  18. 18
    Garnett P. McMillan, Sandra C. Lapham, Does moderate alcohol use affect health-care costs? A propensity analysis of female health-care workers, Addiction, 2004, 99, 5
  19. 19
    Joyce A. Cramer, David Blum, Kristina Fanning, Michael Reed, The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy, Epilepsy & Behavior, 2004, 5, 3, 337

    CrossRef

  20. 20
    Irene A.W. Kotsopoulos, Silvia M.A.A. Evers, André J.H.A. Ament, Fons G.H. Kessels, Marc C.T.F.M. de Krom, Mascha Twellaar, Job F.M. Metsemakers, André J. Knottnerus, The costs of epilepsy in three different populations of patients with epilepsy, Epilepsy Research, 2003, 54, 2-3, 131

    CrossRef

  21. 21
    Pierre Levy, Economic Evaluation of Antiepileptic Drug Therapy: A Methodologic Review, Epilepsia, 2002, 43, 5
  22. 22
    Charles E. Begley, Ettore Beghi, Roy G. Beran, Dominic Heaney, John T. Langfitt, Christopher Pachlatko, Herbert Silfvenius, Michael R. Sperling, Samuel Wiebe, ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: Final Report 1998–2001, Epilepsia, 2002, 43, 6
  23. 23
    D. Mapel, M. Pearson, Obtaining evidence for use by healthcare payers on the success of chronic obstructive pulmonary disease management, Respiratory Medicine, 2002, 96, S23

    CrossRef